Can Fite Biopharma Ltd ADR (CANF) Stock Analysis

Sector: HEALTHCARE - BIOTECHNOLOGY

Exchange: NYSE MKT

Key Metrics

• Price: $4.84
• Market Cap: $15.24M
• 52-Week High: $46.60
• 52-Week Low: $3.36

Market Sentiment

Can Fite Biopharma Ltd ADR currently has a Neutral sentiment score of 0.09.

About Can Fite Biopharma Ltd ADR

Can-Fite BioPharma Ltd. (CANF) is a clinical-stage biopharmaceutical company headquartered in Petah-Tikva, Israel, focused on developing innovative small molecule therapeutics targeting a range of serious illnesses, including cancer, liver and inflammatory diseases, COVID-19, and erectile dysfunction. With a robust pipeline anchored by clinical trials, Can-Fite is committed to addressing unmet medical needs through its proprietary drug candidates. The company’s technology platform leverages t...

GNG Research provides proprietary Safety Scores, Quality Scores, Fair Value estimates, and Valuation Ratings for Can Fite Biopharma Ltd ADR and 4,500+ other companies. Learn more about GNG Pro.

Frequently Asked Questions

Does CANF pay dividends?

Can Fite Biopharma Ltd ADR (CANF) does not currently pay a regular dividend.

What is CANF's market cap?

Can Fite Biopharma Ltd ADR (CANF) has a market capitalization of $15.24M with a current stock price of $4.84.